Condition: Metastatic Breast Cancer · Sponsor: Dr. Christopher Mueller
The goal of this observational study is to assess the effectiveness of the mDETECT breast cancer blood test at monitoring treatment response in women with metastatic breast cancer undergoing treatment.
This description comes directly from the study's public registry record.
Christopher R Mueller, Ph.D. · 613-533-6751 · muellerc@queensu.ca
Keira Frosst · 613-533-6773 · 16kmf4@queensu.ca
Always discuss trial participation with your own doctor first.
| Kingston Health Sciences Centre - Cancer Centre of Southeastern Ontario | Kingston, Ontario, Canada | Recruiting |
| Sunnybrook Health Sciences Centre | Toronto, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05804578